TPS + CBT for Pain

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study aims to evaluate the impact of a Transitional Pain Service (TPS) on hospital readmission rates, opioid consumption, and chronic post-surgical pain(CPSP), Despite increasing recognition of the benefits of integrated transitional pain care, there are limited prospective data evaluating its impact on 30-day readmissions, longitudinal opioid use, and CPSP. This protocol will systematically collect prospective patient data to assess these outcomes.

Who Is on the Research Team?

LK

Lakshmi Koyyalagunta, MD

Principal Investigator

UT MD Anderson Cancer Center

Are You a Good Fit for This Trial?

Inclusion Criteria

I take a daily opioid dose equal to or higher than 90 mg of morphine.
Patients with a history of or current substance use
I have seen a transitional pain specialist.
See 1 more

Exclusion Criteria

Not seen by transitional pain service

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: No-CBT: TPS Patients Not Receiving Mini-CBTExperimental Treatment1 Intervention
Group II: CBT: TPS Patients Receiving Mini-CBTExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+